View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Humana Healthy Horizons Commits $500K to Improve Health of Louisianian...

BATON ROUGE, La.--(BUSINESS WIRE)-- Humana Healthy Horizons, the Medicaid business of leading health and well-being company (NYSE: HUM), announced today that it will invest $500,000 in 2024 in support of community organizations across Louisiana. This press release features multimedia. View the full release here: Humana Healthy Horizons is investing $500,000 in support of community organizations throughout Louisiana in 2024. The investments are intended to help address health-related social needs in the state, with a particular emphasis on maternal health. (Photo: Business Wire) The investmen...

 PRESS RELEASE

Humana Focuses on Reducing Health Disparities and Making Healthy Livin...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, announced the release of its , which includes details on the company’s continued commitment to improving the health outcomes for all as the foundation of its Environmental, Social and Governance (ESG) impact platform. The Impact Report covers Humana’s economic, social and environmental impacts in 2023, highlighting the company’s efforts to inspire and prioritize well-being among people, communities, the healthcare system and the environment. This press release features mult...

 PRESS RELEASE

Humana Healthy Horizons – Ohio partners with CPESN® USA to expand acce...

COLUMBUS, Ohio--(BUSINESS WIRE)-- Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana, announced it is partnering with CPESN® USA in Ohio to expand access to pharmacists for its members throughout the state. This press release features multimedia. View the full release here: Residents of rural and underserved communities often rely on local pharmacies for health care services beyond prescription fulfillment. They may visit their local pharmacy for chronic condition management, screenings, vaccinations, and much more. “Our partnership with CPESN US...

 PRESS RELEASE

Humana and DUOS Launch Groundbreaking Initiative Enhancing Care for U....

LOUISVILLE, Ky.--(BUSINESS WIRE)-- . (NYSE: HUM) and , a technology-enabled service provider announces a new collaborative program to enhance the healthcare experience and improve health outcomes for Louisiana Veteran members with chronic conditions. This press release features multimedia. View the full release here: Humana strives to understand barriers to good health faced by Veterans and their families. We have long standing relationships with Veteran service organizations, and we actively work to address the needs of Veteran communities. (Photo: Business Wire) “When healthcare professiona...

Moody’s rates UnitedHealth Group’s senior notes A2; outlook stable

Approximately $5.0 billion of new debt securities rated New York , March 19, 2024 – Moody's Ratings ("Moody's") has assigned an A2 senior unsecured debt rating to UnitedHealth Group Incorporated's (UnitedHealth, NYSE: UNH) planned issuance of an estimated $5.0 billion of senior unsecured debt due in...

Valens Research
  • Valens Research

CNC - Valens Credit Report - 2024 03 13

Cash bond markets are overstating CNC's credit risk with a YTW of 5.617% relative to an Intrinsic YTW of 4.827%, while CDS markets are slightly overstating credit risk with a CDS of 126bps relative to an Intrinsic CDS of 69bps. Furthermore, Moody's is overstating CNC's fundamental credit risk with its Ba1 credit rating three notches below Valens' IG4+ (Baa1) credit rating. Incentives Dictate Behavior™ analysis highlights mixed signals for credit holders. As positives, most management members ar...

Valens Research
  • Valens Research

Valens Equity Weekly Insights - 2024 03 12

Centene (CNC) is the largest managed health care provider for Medicaid and one of the top providers for Medicare as well with over 26 million members across all of its services. Uniform Accounting highlights that the market is overly pessimistic given exaggerated fears surrounding government spending, suggesting the potential for equity upside. Centene is one of the largest managed care organizations (“MCO”) in the United States. The company provides healthcare services to nearly one in 15...

Moody’s rates Humana’s senior notes Baa2; outlook stable

New York , March 11, 2024 – Moody's Ratings (Moody's) has assigned a Baa2 senior unsecured debt rating to Humana Inc.'s (Humana, NYSE: HUM, senior debt at Baa2) planned issuance of $2.0 billion of senior unsecured notes due in 2031 and 2054. The net proceeds of this transaction are for general corpo...

 PRESS RELEASE

Humana and Strive Health Announce Expansion of Holistic, Patient-Cente...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Leading health and well-being company (NYSE: HUM) and kidney care provider have announced a new value-based care multi-state agreement for most Humana Medicare Advantage HMO and PPO plan members who live with kidney disease. This press release features multimedia. View the full release here: is a holistic, patient-centered healthcare model that focuses on a coordinated effort to help improve patient health outcomes and quality of life. With this agreement, members with chronic kidney disease and end-stage kidney disease in Indiana, Illinois, Kentucky, Mi...

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2024 02 27

Cash bond markets are overstating MOH's credit risk with a YTW of 6.033% relative to an Intrinsic YTW of 5.103%, while CDS markets are slightly overstating credit risk with a CDS of 152bps relative to an Intrinsic CDS of 83bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate BehaviorTM analysis highlights mostly negative signals for credit holders. As a...

UnitedHealth Group Incorporated: Ransomware attack at Change Healthcar...

The ransomware attack appears contained, and although it poses risks, we do not expect any effect on the rating or outlook.

 PRESS RELEASE

Humana Announces Strategic Partnership with Veda to Improve Accuracy o...

LOUISVILLE, Ky. & MADISON, Wis.--(BUSINESS WIRE)-- Leading health and well-being company (NYSE: HUM) today announced a strategic partnership with , a health technology company specializing in helping healthcare companies solve complex provider data challenges. Humana will partner with Veda to improve the accuracy of its provider information and ensure that seniors have real-time details about in-network providers, making it easier for them to access high-quality healthcare. Ensuring the accuracy of provider directories has been the source of ongoing challenges for seniors, health plans, pro...

Humana Inc: 1 director

A director at Humana Inc bought 545 shares at 367.094USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Molina Healthcare Inc: 1 director

A director at Molina Healthcare Inc sold 1,000 shares at 401.050USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

 PRESS RELEASE

CenterWell Pharmacy furthers digital strategy with launch of new mobil...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- CenterWell Pharmacy® has introduced a new mobile app that lets customers manage their prescriptions anytime and anywhere, requesting refills, shopping for over-the-counter products, tracking orders and more. This press release features multimedia. View the full release here: The new CenterWell Pharmacy mobile app includes a simplified dashboard for customers. (Graphic: Business Wire) Thanks to a total redesign and increased personalization capabilities, the new app streamlines prescription management so customers can focus on getting their medicine quickly ...

Centene Corp: 1 director

A director at Centene Corp sold 12,000 shares at 75.068USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

 PRESS RELEASE

Humana Releases Results from Innovative Health Literacy and Healthcare...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM), a leading U.S. health insurer and healthcare services company, continues to make strides in advancing health equity by releasing the findings of its new pilot study published in the . Humana’s screenings analysis marks the first study conducted by a national health plan, focusing on the often overlooked but critical aspects of structural determinants of health, like perceived discrimination and health literacy. “Learnings from this pilot have been very informative for our business and have led to a number of programs and interventio...

Humana Inc.: Humana’s 2023 earnings miss reflects broader struggles wi...

Humana reported Q4 and 2023 earnings significantly below guidance, reflecting higher-than-expected Medicare Advantage claims costs.

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2024 01 17

Valens Credit Research team highlights MOH, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch